<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD09760000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P01584</UniProt_ID>
  <Seq_Length>269</Seq_Length>
  <Molecule_Weight>30748</Molecule_Weight>
  <KEGG_ID>hsa:3553</KEGG_ID>
  <Orthology_ID>K04519</Orthology_ID>
  <Function_Summary>Produced by activated macrophages, IL-1 stimulates thymocyte proliferation by inducing IL-2 release, B-cell maturation and proliferation, and fibroblast growth factor activity. IL-1 proteins are involved in the inflammatory response, being identified as endogenous pyrogens, and are reported to stimulate the release of prostaglandin and collagenase from synovial cells.</Function_Summary>
  <Pfam_ID>PF00340:IL1@@PF02394:IL1_propep</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>IL-1 beta</Alias>
      <Alias>Catabolin</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the interleukin-1 receptor.</Detail>
      <Keyword>Interleukin-1 receptor binding</Keyword>
      <Ontology_ID>GO:0005149</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Functions to control the survival, growth, differentiation and effector function of tissues and cells.</Detail>
      <Keyword>Cytokine activity</Keyword>
      <Ontology_ID>GO:0005125</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of transfer of NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters, from the cytoplasm into the nucleus, across the nuclear membrane.</Detail>
      <Keyword>Positive regulation of NF-kappaB import into nucleus</Keyword>
      <Ontology_ID>GO:0042346</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.</Detail>
      <Keyword>Cellular response to mechanical stimulus</Keyword>
      <Ontology_ID>GO:0071260</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cellular DNA-dependent transcription.</Detail>
      <Keyword>Positive regulation of transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0045893</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of an I-kappaB kinase/NF-kappaB induced cascade.</Detail>
      <Keyword>Positive regulation of I-kappaB kinase/NF-kappaB cascade</Keyword>
      <Ontology_ID>GO:0043123</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases angiogenesis.</Detail>
      <Keyword>Positive regulation of angiogenesis</Keyword>
      <Ontology_ID>GO:0045766</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the frequency, rate or extent of glucose transport. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Negative regulation of glucose transport</Keyword>
      <Ontology_ID>GO:0010829</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.</Detail>
      <Keyword>Positive regulation of nitric oxide biosynthetic process</Keyword>
      <Ontology_ID>GO:0045429</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.</Detail>
      <Keyword>Negative regulation of MAP kinase activity</Keyword>
      <Ontology_ID>GO:0043407</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to a histone protein.</Detail>
      <Keyword>Positive regulation of histone acetylation</Keyword>
      <Ontology_ID>GO:0035066</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of myosin light chain kinase activity.</Detail>
      <Keyword>Positive regulation of myosin light chain kinase activity</Keyword>
      <Ontology_ID>GO:0035505</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.</Detail>
      <Keyword>Positive regulation of NF-kappaB transcription factor activity</Keyword>
      <Ontology_ID>GO:0051092</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of a cytokine or chemokine binding to a cell surface receptor.</Detail>
      <Keyword>Cytokine-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0019221</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of transcription from the RNA polymerase II promoter.</Detail>
      <Keyword>Positive regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0045944</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.</Detail>
      <Keyword>Negative regulation of insulin receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0046627</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-2.</Detail>
      <Keyword>Positive regulation of interleukin-2 biosynthetic process</Keyword>
      <Ontology_ID>GO:0045086</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency or extent of calcidiol 1-monooxygenase activity. Calcidiol 1-monooxygenase activity is the catalysis of the reaction: calcidiol + NADPH + H+ + O2 = calcitriol + NADP+ + H2O.</Detail>
      <Keyword>Positive regulation of calcidiol 1-monooxygenase activity</Keyword>
      <Ontology_ID>GO:0060559</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm.</Detail>
      <Keyword>Positive regulation of protein export from nucleus</Keyword>
      <Ontology_ID>GO:0046827</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which smooth muscle adapts, with consequent modifications to structural and/or functional phenotypes, in response to a stimulus. Stimuli include contractile activity, loading conditions, substrate supply, and environmental factors. These adaptive events occur in both muscle fibers and associated structures (motoneurons and capillaries), and they involve alterations in regulatory mechanisms, contractile properties and metabolic capacities.</Detail>
      <Keyword>Smooth muscle adaptation</Keyword>
      <Ontology_ID>GO:0014805</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.</Detail>
      <Keyword>Positive regulation of lipid catabolic process</Keyword>
      <Ontology_ID>GO:0050996</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.</Detail>
      <Keyword>Cellular response to drug</Keyword>
      <Ontology_ID>GO:0035690</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B, which occurs as a result of a single trigger reaction or compound.</Detail>
      <Keyword>Protein kinase B signaling cascade</Keyword>
      <Ontology_ID>GO:0043491</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cascade of at least three protein kinase activities culminating in the phosphorylation and activation of a MAP kinase. MAPKKK cascades lie downstream of numerous signaling pathways.</Detail>
      <Keyword>MAPKKK cascade</Keyword>
      <Ontology_ID>GO:0000165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade.</Detail>
      <Keyword>Positive regulation of JNK cascade</Keyword>
      <Ontology_ID>GO:0046330</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production.</Detail>
      <Keyword>Positive regulation of granulocyte macrophage colony-stimulating factor production</Keyword>
      <Ontology_ID>GO:0032725</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.</Detail>
      <Keyword>Immune response</Keyword>
      <Ontology_ID>GO:0006955</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of production of monocyte chemotactic protein-1.</Detail>
      <Keyword>Positive regulation of monocyte chemotactic protein-1 production</Keyword>
      <Ontology_ID>GO:0071639</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.</Detail>
      <Keyword>Positive regulation of interleukin-6 biosynthetic process</Keyword>
      <Ontology_ID>GO:0045410</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the regulated release of a prostaglandin from a cell or group of cells.</Detail>
      <Keyword>Positive regulation of prostaglandin secretion</Keyword>
      <Ontology_ID>GO:0032308</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.</Detail>
      <Keyword>Positive regulation of vascular endothelial growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0030949</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cell division.</Detail>
      <Keyword>Positive regulation of cell division</Keyword>
      <Ontology_ID>GO:0051781</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of adiponectin from a cell or group of cells.</Detail>
      <Keyword>Negative regulation of adiponectin secretion</Keyword>
      <Ontology_ID>GO:0070164</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the addition of one or more phosphate groups to a histone protein.</Detail>
      <Keyword>Positive regulation of histone phosphorylation</Keyword>
      <Ontology_ID>GO:0033129</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.</Detail>
      <Keyword>Positive regulation of heterotypic cell-cell adhesion</Keyword>
      <Ontology_ID>GO:0034116</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate or extent of cell proliferation.</Detail>
      <Keyword>Negative regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008285</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines.</Detail>
      <Keyword>Positive regulation of chemokine biosynthetic process</Keyword>
      <Ontology_ID>GO:0045080</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.</Detail>
      <Keyword>Negative regulation of lipid catabolic process</Keyword>
      <Ontology_ID>GO:0050995</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of fever generation.</Detail>
      <Keyword>Positive regulation of fever generation</Keyword>
      <Ontology_ID>GO:0031622</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.</Detail>
      <Keyword>Positive regulation of interleukin-6 production</Keyword>
      <Ontology_ID>GO:0032755</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.</Detail>
      <Keyword>Positive regulation vascular endothelial growth factor production</Keyword>
      <Ontology_ID>GO:0010575</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Attachment of the blastocyst to the uterine lining.</Detail>
      <Keyword>Embryo implantation</Keyword>
      <Ontology_ID>GO:0007566</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.</Detail>
      <Keyword>Neutrophil chemotaxis</Keyword>
      <Ontology_ID>GO:0030593</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.</Detail>
      <Keyword>Cellular response to organic cyclic compound</Keyword>
      <Ontology_ID>GO:0071407</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme MAP kinase by phosphorylation by a MAPKK.</Detail>
      <Keyword>Activation of MAPK activity</Keyword>
      <Ontology_ID>GO:0000187</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.</Detail>
      <Keyword>Positive regulation of interleukin-8 production</Keyword>
      <Ontology_ID>GO:0032757</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of mitosis.</Detail>
      <Keyword>Positive regulation of mitosis</Keyword>
      <Ontology_ID>GO:0045840</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of T cell mediated immunity.</Detail>
      <Keyword>Positive regulation of T cell mediated immunity</Keyword>
      <Ontology_ID>GO:0002711</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.</Detail>
      <Keyword>Positive regulation of interferon-gamma production</Keyword>
      <Ontology_ID>GO:0032729</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus.</Detail>
      <Keyword>Response to ATP</Keyword>
      <Ontology_ID>GO:0033198</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The heat generation process that results in a rise in body temperature above the normal, often as a response to infection.</Detail>
      <Keyword>Fever generation</Keyword>
      <Ontology_ID>GO:0001660</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated in response to detection of lipopolysaccharide. Lipopolysaccharides (LPS) are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.</Detail>
      <Keyword>Lipopolysaccharide-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0031663</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptosis.</Detail>
      <Keyword>Negative regulation of apoptosis</Keyword>
      <Ontology_ID>GO:0043066</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The adhesion of one monocyte to one or more other monocytes via adhesion molecules.</Detail>
      <Keyword>Monocyte aggregation</Keyword>
      <Ontology_ID>GO:0070487</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The appearance of interleukin-1 beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.</Detail>
      <Keyword>Interleukin-1 beta production</Keyword>
      <Ontology_ID>GO:0032611</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency or extent of cell adhesion molecule production. Cell adhesion molecule production is the appearance of a cell adhesion molecule as a result of its biosynthesis or a decrease in its catabolism.</Detail>
      <Keyword>Positive regulation of cell adhesion molecule production</Keyword>
      <Ontology_ID>GO:0060355</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of binding or confining any triester of glycerol such that it is separated from other components of a biological system.</Detail>
      <Keyword>Sequestering of triglyceride</Keyword>
      <Ontology_ID>GO:0030730</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the regulated release of insulin.</Detail>
      <Keyword>Regulation of insulin secretion</Keyword>
      <Ontology_ID>GO:0050796</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that mediates the transfer of information from one cell to another.</Detail>
      <Keyword>Cell-cell signaling</Keyword>
      <Ontology_ID>GO:0007267</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of T cell proliferation.</Detail>
      <Keyword>Positive regulation of T cell proliferation</Keyword>
      <Ontology_ID>GO:0042102</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of membrane protein ectodomain peptidolysis.</Detail>
      <Keyword>Positive regulation of membrane protein ectodomain proteolysis</Keyword>
      <Ontology_ID>GO:0051044</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.</Detail>
      <Keyword>Hyaluronan biosynthetic process</Keyword>
      <Ontology_ID>GO:0030213</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS</Protein_Seq>
    <DNA_Seq>ACCAAACCTCTTCGAGGCACAAGGCACAACAGGCTGCTCTGGGATTCTCTTCAGCCAATCTTCATTGCTCAAGTGTCTGAAGCAGCCATGGCAGAAGTACCTGAGCTCGCCAGTGAAATGATGGCTTATTACAGTGGCAATGAGGATGACTTGTTCTTTGAAGCTGATGGCCCTAAACAGATGAAGTGCTCCTTCCAGGACCTGGACCTCTGCCCTCTGGATGGCGGCATCCAGCTACGAATCTCCGACCACCACTACAGCAAGGGCTTCAGGCAGGCCGCGTCAGTTGTTGTGGCCATGGACAAGCTGAGGAAGATGCTGGTTCCCTGCCCACAGACCTTCCAGGAGAATGACCTGAGCACCTTCTTTCCCTTCATCTTTGAAGAAGAACCTATCTTCTTCGACACATGGGATAACGAGGCTTATGTGCACGATGCACCTGTACGATCACTGAACTGCACGCTCCGGGACTCACAGCAAAAAAGCTTGGTGATGTCTGGTCCATATGAACTGAAAGCTCTCCACCTCCAGGGACAGGATATGGAGCAACAAGTGGTGTTCTCCATGTCCTTTGTACAAGGAGAAGAAAGTAATGACAAAATACCTGTGGCCTTGGGCCTCAAGGAAAAGAATCTGTACCTGTCCTGCGTGTTGAAAGATGATAAGCCCACTCTACAGCTGGAGAGTGTAGATCCCAAAAATTACCCAAAGAAGAAGATGGAAAAGCGATTTGTCTTCAACAAGATAGAAATCAATAACAAGCTGGAATTTGAGTCTGCCCAGTTCCCCAACTGGTACATCAGCACCTCTCAAGCAGAAAACATGCCCGTCTTCCTGGGAGGGACCAAAGGCGGCCAGGATATAACTGACTTCACCATGCAATTTGTGTCTTCCTAAAGAGAGCTGTACCCAGAGAGTCCTGTGCTGAATGTGGACTCAATCCCTAGGGCTGGCAGAAAGGGAACAGAAAGGTTTTTGAGTACGGCTATAGCCTGGACTTTCCTGTTGTCTACACCAATGCCCAACTGCCTGCCTTAGGGTAGTGCTAAGAGGATCTCCTGTCCATCAGCCAGGACAGTCAGCTCTCTCCTTTCAGGGCCAATCCCCAGCCCTTTTGTTGAGCCAGGCCTCTCTCACCTCTCCTACTCACTTAAAGCCCGCCTGACAGAAACCACGGCCACATTTGGTTCTAAGAAACCCTCTGTCATTCGCTCCCACATTCTGATGAGCAACCGCTTCCCTATTTATTTATTTATTTGTTTGTTTGTTTTATTCATTGGTCTAATTTATTCAAAGGGGGCAAGAAGTAGCAGTGTCTGTAAAAGAGCCTAGTTTTTAATAGCTATGGAATCAATTCAATTTGGACTGGTGTGCTCTCTTTAAATCAAGTCCTTTAATTAAGACTGAAAATATATAAGCTCAGATTATTTAAATGGGAATATTTATAAATGAGCAAATATCATACTGTTCAATGGTTCTGAAATAAACTTCACTGAAG</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Stored secretory granule</CellLocal>
      <Ontology_ID>GO:0030141</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular space</CellLocal>
      <Ontology_ID>GO:0005615</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>IL1B</Gene_Name>
    <Gene_Alias>IL1F2</Gene_Alias>
    <Gene_ID>3553</Gene_ID>
    <Genbank_ACCN>NM_000576</Genbank_ACCN>
    <Protein_ACCN>NP_000567</Protein_ACCN>
    <HGNC_ID>5992</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/3553</Gene_URL>
    <UCSC_ID>uc002tih.1</UCSC_ID>
    <EMBL_ID>ENSG00000125538</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Euthyroid Sick Syndrome</Disease_Name>
      <Disease_Detail>Euthyroid Sick Syndrome</Disease_Detail>
      <Disease_DB>ETH004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/euthyroid_sick_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Idiopathic Pulmonary Alveolar Proteinosis</Disease_Name>
      <Disease_Detail>Idiopathic Pulmonary Alveolar Proteinosis</Disease_Detail>
      <Disease_DB>IDP044</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/idiopathic_pulmonary_alveolar_proteinosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastroesophageal Junction Adenocarcinoma</Disease_Name>
      <Disease_Detail>Gastroesophageal Junction Adenocarcinoma</Disease_Detail>
      <Disease_DB>GST012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastroesophageal_junction_adenocarcinoma?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malaria</Disease_Name>
      <Disease_Detail>Malaria</Disease_Detail>
      <Disease_DB>MLR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malaria?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Poems Syndrome</Disease_Name>
      <Disease_Detail>Poems Syndrome</Disease_Detail>
      <Disease_DB>PMS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/poems_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colitis</Disease_Name>
      <Disease_Detail>Colitis</Disease_Detail>
      <Disease_DB>CLT003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tuberculosis</Disease_Name>
      <Disease_Detail>Tuberculosis</Disease_Detail>
      <Disease_DB>TBR010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tuberculosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chorioamnionitis</Disease_Name>
      <Disease_Detail>Chorioamnionitis</Disease_Detail>
      <Disease_DB>CHR005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chorioamnionitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vaginitis</Disease_Name>
      <Disease_Detail>Vaginitis</Disease_Detail>
      <Disease_DB>VGN023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vaginitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bagassosis</Disease_Name>
      <Disease_Detail>Bagassosis</Disease_Detail>
      <Disease_DB>BGS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bagassosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malignant Histiocytosis</Disease_Name>
      <Disease_Detail>Malignant Histiocytosis</Disease_Detail>
      <Disease_DB>MLG054</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malignant_histiocytosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Familial Cold Autoinflammatory Syndrome</Disease_Name>
      <Disease_Detail>Familial Cold Autoinflammatory Syndrome</Disease_Detail>
      <Disease_DB>FML052</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/familial_cold_autoinflammatory_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Periodontitis</Disease_Name>
      <Disease_Detail>Periodontitis</Disease_Detail>
      <Disease_DB>PRD008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/periodontitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Shigellosis</Disease_Name>
      <Disease_Detail>Shigellosis</Disease_Detail>
      <Disease_DB>SHG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/shigellosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Meningococcemia</Disease_Name>
      <Disease_Detail>Meningococcemia</Disease_Detail>
      <Disease_DB>MNN021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/meningococcemia?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Diffuse Gastric Cancer</Disease_Name>
      <Disease_Detail>Hereditary Diffuse Gastric Cancer</Disease_Detail>
      <Disease_DB>HRD027</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_diffuse_gastric_cancer?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Somatoform Disorder</Disease_Name>
      <Disease_Detail>Somatoform Disorder</Disease_Detail>
      <Disease_DB>SMT006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/somatoform_disorder?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Fascioliasis</Disease_Name>
      <Disease_Detail>Fascioliasis</Disease_Detail>
      <Disease_DB>FSC002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/fascioliasis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Laryngitis</Disease_Name>
      <Disease_Detail>Laryngitis</Disease_Detail>
      <Disease_DB>LRY019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/laryngitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acrodermatitis</Disease_Name>
      <Disease_Detail>Acrodermatitis</Disease_Detail>
      <Disease_DB>ACR005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acrodermatitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Stenotrophomonas Maltophilia</Disease_Name>
      <Disease_Detail>Stenotrophomonas Maltophilia</Disease_Detail>
      <Disease_DB>STN007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/stenotrophomonas_maltophilia?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Corneal Ulcer</Disease_Name>
      <Disease_Detail>Corneal Ulcer</Disease_Detail>
      <Disease_DB>CRN028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/corneal_ulcer?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endotoxin Hyporesponsiveness</Disease_Name>
      <Disease_Detail>Endotoxin Hyporesponsiveness</Disease_Detail>
      <Disease_DB>END048</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endotoxin_hyporesponsiveness?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Idiopathic Neutropenia</Disease_Name>
      <Disease_Detail>Idiopathic Neutropenia</Disease_Detail>
      <Disease_DB>IDP064</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/idiopathic_neutropenia?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Toxic Shock Syndrome</Disease_Name>
      <Disease_Detail>Toxic Shock Syndrome</Disease_Detail>
      <Disease_DB>TXC005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/toxic_shock_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leukocyte Adhesion Deficiency</Disease_Name>
      <Disease_Detail>Leukocyte Adhesion Deficiency</Disease_Detail>
      <Disease_DB>LKC001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leukocyte_adhesion_deficiency?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Crohn's Colitis</Disease_Name>
      <Disease_Detail>Crohn's Colitis</Disease_Detail>
      <Disease_DB>CRH005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/crohns_colitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Extrapulmonary Tuberculosis</Disease_Name>
      <Disease_Detail>Extrapulmonary Tuberculosis</Disease_Detail>
      <Disease_DB>EXT033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/extrapulmonary_tuberculosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Corneal Edema</Disease_Name>
      <Disease_Detail>Corneal Edema</Disease_Detail>
      <Disease_DB>CRN026</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/corneal_edema?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Diffuse Gastric Cancer</Disease_Name>
      <Disease_Detail>Diffuse Gastric Cancer</Disease_Detail>
      <Disease_DB>DFF019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/diffuse_gastric_cancer?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intervertebral Disc Disease</Disease_Name>
      <Disease_Detail>Intervertebral Disc Disease</Disease_Detail>
      <Disease_DB>INT146</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intervertebral_disc_disease?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Central Nervous System Leukemia</Disease_Name>
      <Disease_Detail>Central Nervous System Leukemia</Disease_Detail>
      <Disease_DB>CNT018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/central_nervous_system_leukemia?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cryopyrin-Associated Periodic Syndrome</Disease_Name>
      <Disease_Detail>Cryopyrin-Associated Periodic Syndrome</Disease_Detail>
      <Disease_DB>CRY008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cryopyrin_associated_periodic_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Viral Encephalitis</Disease_Name>
      <Disease_Detail>Viral Encephalitis</Disease_Detail>
      <Disease_DB>VRL007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/viral_encephalitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Staphylococcal Toxic Shock Syndrome</Disease_Name>
      <Disease_Detail>Staphylococcal Toxic Shock Syndrome</Disease_Detail>
      <Disease_DB>STP004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/staphylococcal_toxic_shock_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Aseptic Meningitis</Disease_Name>
      <Disease_Detail>Aseptic Meningitis</Disease_Detail>
      <Disease_DB>ASP003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/aseptic_meningitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Recurrent Corneal Erosion</Disease_Name>
      <Disease_Detail>Recurrent Corneal Erosion</Disease_Detail>
      <Disease_DB>RCR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/recurrent_corneal_erosion?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pharyngitis</Disease_Name>
      <Disease_Detail>Pharyngitis</Disease_Detail>
      <Disease_DB>PHR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pharyngitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tuberculous Meningitis</Disease_Name>
      <Disease_Detail>Tuberculous Meningitis</Disease_Detail>
      <Disease_DB>TBR011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tuberculous_meningitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nephropathia Epidemica</Disease_Name>
      <Disease_Detail>Nephropathia Epidemica</Disease_Detail>
      <Disease_DB>NPH004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nephropathia_epidemica?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vulvar Vestibulitis Syndrome</Disease_Name>
      <Disease_Detail>Vulvar Vestibulitis Syndrome</Disease_Detail>
      <Disease_DB>VLV042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vulvar_vestibulitis_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Campylobacteriosis</Disease_Name>
      <Disease_Detail>Campylobacteriosis</Disease_Detail>
      <Disease_DB>CMP002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/campylobacteriosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Meningitis</Disease_Name>
      <Disease_Detail>Meningitis</Disease_Detail>
      <Disease_DB>MNN013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/meningitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Paratyphoid Fever</Disease_Name>
      <Disease_Detail>Paratyphoid Fever</Disease_Detail>
      <Disease_DB>PRT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/paratyphoid_fever?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Periodontal Disease</Disease_Name>
      <Disease_Detail>Periodontal Disease</Disease_Detail>
      <Disease_DB>PRD007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/periodontal_disease?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Wells Syndrome</Disease_Name>
      <Disease_Detail>Wells Syndrome</Disease_Detail>
      <Disease_DB>WLL006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/wells_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Erdheim-Chester Disease</Disease_Name>
      <Disease_Detail>Erdheim-Chester Disease</Disease_Detail>
      <Disease_DB>ERD001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/erdheim_chester_disease?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Plasmodium Vivax Malaria</Disease_Name>
      <Disease_Detail>Plasmodium Vivax Malaria</Disease_Detail>
      <Disease_DB>PLS006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/plasmodium_vivax_malaria?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Funisitis</Disease_Name>
      <Disease_Detail>Funisitis</Disease_Detail>
      <Disease_DB>FNS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/funisitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Burning Mouth Syndrome</Disease_Name>
      <Disease_Detail>Burning Mouth Syndrome</Disease_Detail>
      <Disease_DB>BRN009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/burning_mouth_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastric Cancer Risk After H. Pylori Infection</Disease_Name>
      <Disease_Detail>Gastric Cancer</Disease_Detail>
      <Disease_DB>GST063</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastric_cancer_risk_after_h_pylori_infection?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bacterial Vaginosis</Disease_Name>
      <Disease_Detail>Bacterial Vaginosis</Disease_Detail>
      <Disease_DB>BCT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bacterial_vaginosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Stachybotrys Chartarum</Disease_Name>
      <Disease_Detail>Stachybotrys Chartarum</Disease_Detail>
      <Disease_DB>STC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/stachybotrys_chartarum?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lumbar Disc Disease</Disease_Name>
      <Disease_Detail>Lumbar Disc Disease</Disease_Detail>
      <Disease_DB>LMB051</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lumbar_disc_disease?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Extrinsic Allergic Alveolitis</Disease_Name>
      <Disease_Detail>Extrinsic Allergic Alveolitis</Disease_Detail>
      <Disease_DB>EXT034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/extrinsic_allergic_alveolitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dengue Shock Syndrome</Disease_Name>
      <Disease_Detail>Dengue Shock Syndrome</Disease_Detail>
      <Disease_DB>DNG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dengue_shock_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Blau Syndrome</Disease_Name>
      <Disease_Detail>Blau Syndrome</Disease_Detail>
      <Disease_DB>BLS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/blau_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>H. Pylori Infection</Disease_Name>
      <Disease_Detail>H. Pylori Infection</Disease_Detail>
      <Disease_DB>HPY002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/h_pylori_infection?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prosthetic Joint Infection</Disease_Name>
      <Disease_Detail>Prosthetic Joint Infection</Disease_Detail>
      <Disease_DB>PRS115</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prosthetic_joint_infection?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Palindromic Rheumatism</Disease_Name>
      <Disease_Detail>Palindromic Rheumatism</Disease_Detail>
      <Disease_DB>PLN005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/palindromic_rheumatism?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiac Sarcoidosis</Disease_Name>
      <Disease_Detail>Cardiac Sarcoidosis</Disease_Detail>
      <Disease_DB>CRD003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiac_sarcoidosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cervical Adenitis</Disease_Name>
      <Disease_Detail>Cervical Adenitis</Disease_Detail>
      <Disease_DB>CRV030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cervical_adenitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastric Cancer</Disease_Name>
      <Disease_Detail>Gastric Cancer</Disease_Detail>
      <Disease_DB>GST053</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastric_cancer?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spondylosis</Disease_Name>
      <Disease_Detail>Spondylosis</Disease_Detail>
      <Disease_DB>SPN020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spondylosis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Rheumatoid Arthritis</Disease_Name>
      <Disease_Detail>Rheumatoid Arthritis</Disease_Detail>
      <Disease_DB>RHM011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rheumatoid_arthritis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Opisthorchiasis</Disease_Name>
      <Disease_Detail>Opisthorchiasis</Disease_Detail>
      <Disease_DB>OPS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/opisthorchiasis?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Classic Kaposi Sarcoma</Disease_Name>
      <Disease_Detail>Classic Kaposi Sarcoma</Disease_Detail>
      <Disease_DB>CLS007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/classic_kaposi_sarcoma?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Muckle-Wells Syndrome</Disease_Name>
      <Disease_Detail>Muckle-Wells Syndrome</Disease_Detail>
      <Disease_DB>MCK007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/muckle_wells_syndrome?search=IL1B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glossitis</Disease_Name>
      <Disease_Detail>Glossitis</Disease_Detail>
      <Disease_DB>GLS007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glossitis?search=IL1B#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Triple mutation in interleukin 1 beta cavity:replacement of phenylalanines with tryptophan.</PDB_Title>
      <PDB_ID>1TP0</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TP0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and energetic consequences of mutations in a solvated hydrophobic cavity.</PubMed_Title>
      <Author>Adamek, D.H., et al.</Author>
      <Journal>J.Mol.Biol.(2005)346:307-318</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15663946?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of an Interleukin-1 receptor complex</PDB_Title>
      <PDB_ID>3O4O</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3O4O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural insights into the assembly and activation of IL-1beta with its receptors</PubMed_Title>
      <Author>Wang, D.L., et al.</Author>
      <Journal>Nat.Immunol.(2010)11:905-911</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20802483?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of Interleukin 1-beta F42W/W120F mutant</PDB_Title>
      <PDB_ID>1L2H</PDB_ID>
      <Resolution>1.54</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1L2H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Use of multiple anomalous dispersion to phase highly merohedrally twinned crystals of interleukin-1beta.</PubMed_Title>
      <Author>Rudolph, M.G., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2003)59:290-298</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12554939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Interleukin 1B Mutant F146W</PDB_Title>
      <PDB_ID>1TOO</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TOO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and energetic consequences of mutations in a solvated hydrophobic cavity.</PubMed_Title>
      <Author>Adamek, D.H., et al.</Author>
      <Journal>J.Mol.Biol.(2005)346:307-318</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15663946?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY SER) (C71S)</PDB_Title>
      <PDB_ID>31BI</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=31BI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The PDB archive contains information about experimentally-determined structures of proteins, nucleic acids, and complex assemblies.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Structure of Interleukin 1B solved by SAD using an inserted Lanthanide Binding Tag</PDB_Title>
      <PDB_ID>3LTQ</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LTQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Engineering encodable lanthanide-binding tags into loop regions of proteins.</PubMed_Title>
      <Author>Barthelmes, K., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2011)133:808-819</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21182275?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN-1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY</PDB_Title>
      <PDB_ID>6I1B</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=6I1B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy.</PubMed_Title>
      <Author>Clore, G.M., et al.</Author>
      <Journal>Biochemistry(1991)30:2315-2323</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2001363?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of a scFv-IL-1B complex</PDB_Title>
      <PDB_ID>2KH2</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2KH2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.</PubMed_Title>
      <Author>Wilkinson, I.C., et al.</Author>
      <Journal>J.Biol.Chem.(2009)284:31928-31935</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19776018?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY ALA) (C71A)</PDB_Title>
      <PDB_ID>21BI</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=21BI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The PDB archive contains information about experimentally-determined structures of proteins, nucleic acids, and complex assemblies.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Interleukin 1 beta F101W</PDB_Title>
      <PDB_ID>1T4Q</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1T4Q</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and energetic consequences of mutations in a solvated hydrophobic cavity.</PubMed_Title>
      <Author>Adamek, D.H., et al.</Author>
      <Journal>J.Mol.Biol.(2005)346:307-318</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15663946?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>INTERLEUKIN 1 BETA MUTANT F101Y</PDB_Title>
      <PDB_ID>1TWE</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TWE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and energetic consequences of mutations in a solvated hydrophobic cavity.</PubMed_Title>
      <Author>Adamek, D.H., et al.</Author>
      <Journal>J.Mol.Biol.(2005)346:307-318</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15663946?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal strucure of human IL-1beta in complex with therapeutic antibody binding fragment of gevokizumab</PDB_Title>
      <PDB_ID>4G6M</PDB_ID>
      <Resolution>1.81</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4G6M</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal strucure of human IL-1beta in complex with therapeutic antibody binding fragment of gevokizumab</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Determination of Solvent Content in Cavities in Interleukin-1 Using Experimentally-Phased Electron Density</PDB_Title>
      <PDB_ID>2NVH</PDB_ID>
      <Resolution>1.53</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2NVH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Determination of solvent content in cavities in IL-1beta using experimentally phased electron density</PubMed_Title>
      <Author>Quillin, M.L., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2006)103:19749-19753</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17179045?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>TYPE-1 INTERLEUKIN-1 RECEPTOR COMPLEXED WITH INTERLEUKIN-1 BETA</PDB_Title>
      <PDB_ID>1ITB</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ITB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.</PubMed_Title>
      <Author>Vigers, G.P., et al.</Author>
      <Journal>Nature(1997)386:190-194</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9062193?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 8 REPLACED BY ALA (C8A)</PDB_Title>
      <PDB_ID>41BI</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=41BI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The PDB archive contains information about experimentally-determined structures of proteins, nucleic acids, and complex assemblies.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Interleukin-1 Beta Mutant F146Y</PDB_Title>
      <PDB_ID>1TWM</PDB_ID>
      <Resolution>2.26</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TWM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and energetic consequences of mutations in a solvated hydrophobic cavity.</PubMed_Title>
      <Author>Adamek, D.H., et al.</Author>
      <Journal>J.Mol.Biol.(2005)346:307-318</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15663946?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Interleukin-1-beta LBT L3 Mutant</PDB_Title>
      <PDB_ID>3POK</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3POK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Engineering encodable lanthanide-binding tags into loop regions of proteins.</PubMed_Title>
      <Author>Barthelmes, K., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2011)133:808-819</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21182275?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN INTERLEUKIN-1 BETA</PDB_Title>
      <PDB_ID>9ILB</PDB_ID>
      <Resolution>2.28</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=9ILB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Disordered water within a hydrophobic protein cavity visualized by x-ray crystallography.</PubMed_Title>
      <Author>Yu, B., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(1999)96:103-108</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9874779?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN-1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY</PDB_Title>
      <PDB_ID>7I1B</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=7I1B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy.</PubMed_Title>
      <Author>Clore, G.M., et al.</Author>
      <Journal>Biochemistry(1991)30:2315-2323</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2001363?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Interleukin 1 beta mutant F42W</PDB_Title>
      <PDB_ID>1S0L</PDB_ID>
      <Resolution>2.34</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1S0L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and energetic consequences of mutations in a solvated hydrophobic cavity.</PubMed_Title>
      <Author>Adamek, D.H., et al.</Author>
      <Journal>J.Mol.Biol.(2005)346:307-318</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15663946?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the IL-1b signaling complex</PDB_Title>
      <PDB_ID>4DEP</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DEP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the activating IL-1 receptor signaling complex.</PubMed_Title>
      <Author>Thomas, C., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2012)19:455-457</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22426547?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab</PDB_Title>
      <PDB_ID>4G6J</PDB_ID>
      <Resolution>2.03</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4G6J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>One traget-two different binding modes: Structural insights into gevokizumab and canakinumab interactions to interleukin-1beta</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>INTERLEUKIN-1 BETA FROM JOINT X-RAY AND NMR REFINEMENT</PDB_Title>
      <PDB_ID>1IOB</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IOB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Combining experimental information from crystal and solution studies: joint X-ray and NMR refinement.</PubMed_Title>
      <Author>Shaanan, B., et al.</Author>
      <Journal>Science(1992)257:961-964</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1502561?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>1I1B</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1I1B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution.</PubMed_Title>
      <Author>Finzel, B.C., et al.</Author>
      <Journal>J.Mol.Biol.(1989)209:779-791</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2585509?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTALLOGRAPHIC REFINEMENT OF INTERLEUKIN-1 BETA AT 2.0 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>2I1B</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2I1B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic refinement of interleukin 1 beta at 2.0 A resolution.</PubMed_Title>
      <Author>Priestle, J.P., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(1989)86:9667-9671</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/2602367?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B</PDB_Title>
      <PDB_ID>5I1B</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=5I1B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Comparison of the High Resolution Structures of Human and Murine Interleukin-1B</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>FUNCTIONAL IMPLICATIONS OF INTERLEUKIN-1BETA BASED ON THE THREE-DIMENSIONAL STRUCTURE</PDB_Title>
      <PDB_ID>4I1B</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4I1B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Functional implications of interleukin-1 beta based on the three-dimensional structure.</PubMed_Title>
      <Author>Veerapandian, B., et al.</Author>
      <Journal>Proteins(1992)12:10-23</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1553379?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE STRUCTURE OF AN INTERLEUKIN-1 BETA MUTANT WITH REDUCED BIOACTIVITY SHOWS MULTIPLE SUBTLE CHANGES IN CONFORMATION THAT AFFECT PROTEIN-PROTEIN RECOGNITION</PDB_Title>
      <PDB_ID>1HIB</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HIB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of an interleukin-1 beta mutant with reduced bioactivity shows multiple subtle changes in conformation that affect protein-protein recognition.</PubMed_Title>
      <Author>Camacho, N.P., et al.</Author>
      <Journal>Biochemistry(1993)32:8749-8757</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8364024?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05142</Pathway_ID>
      <Pathway_Title>Chagas disease (American trypanosomiasis)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04668</Pathway_ID>
      <Pathway_Title>TNF signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04932</Pathway_ID>
      <Pathway_Title>Non-alcoholic fatty liver disease (NAFLD)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Endocrine and metabolic diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04621</Pathway_ID>
      <Pathway_Title>NOD-like receptor signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05140</Pathway_ID>
      <Pathway_Title>Leishmaniasis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05132</Pathway_ID>
      <Pathway_Title>Salmonella infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05134</Pathway_ID>
      <Pathway_Title>Legionellosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04060</Pathway_ID>
      <Pathway_Title>Cytokine-cytokine receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04380</Pathway_ID>
      <Pathway_Title>Osteoclast differentiation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Development</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05321</Pathway_ID>
      <Pathway_Title>Inflammatory bowel disease (IBD)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Immune diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04010</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04640</Pathway_ID>
      <Pathway_Title>Hematopoietic cell lineage</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05020</Pathway_ID>
      <Pathway_Title>Prion diseases</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04620</Pathway_ID>
      <Pathway_Title>Toll-like receptor signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05164</Pathway_ID>
      <Pathway_Title>Influenza A</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05133</Pathway_ID>
      <Pathway_Title>Pertussis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05133</Pathway_ID>
      <Pathway_Title>Pertussis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05144</Pathway_ID>
      <Pathway_Title>Malaria</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04750</Pathway_ID>
      <Pathway_Title>Inflammatory mediator regulation of TRP channels</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04623</Pathway_ID>
      <Pathway_Title>Cytosolic DNA-sensing pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04210</Pathway_ID>
      <Pathway_Title>Apoptosis</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05133</Pathway_ID>
      <Pathway_Title>Pertussis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05164</Pathway_ID>
      <Pathway_Title>Influenza A</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05010</Pathway_ID>
      <Pathway_Title>Alzheimer's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05134</Pathway_ID>
      <Pathway_Title>Legionellosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05143</Pathway_ID>
      <Pathway_Title>African trypanosomiasis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04940</Pathway_ID>
      <Pathway_Title>Type I diabetes mellitus</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Endocrine and metabolic diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05152</Pathway_ID>
      <Pathway_Title>Tuberculosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.hd.b.c.b.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1hib</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Blech M, et al. J Mol Biol. 2012 Oct 3. pii: S0022-2836(12)00786-3. doi: 10.1016/j.jmb.2012.09.021.</Site_Reference>
      <Site_Type>Antibody-induced </Site_Type>
      <PubMed_ID>23041424</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Create_Date>2013-04-23</Create_Date>
</Organism_Record>